As we welcome in 2022, it is an opportune time to look back at the events of the past year and to look forward to the implementation of new initiatives that will keep Cancer Immunology Research on its trajectory of growth. For much of 2021, the challenges of the previous year, brought about as a result of the COVID-19 pandemic, continued. We hope that you have stayed safe and healthy during these most difficult of times.

2021 was also filled with many positives. The year showcased to the world the importance of scientific research and the incredible power of collaboration within the medical research ecosystem as millions of people received a vaccine to protect them from the worst effects of SARS-CoV-2 infection. This unprecedented effort meant that as 2021 progressed, many of us were able to begin shifting our lives back toward something resembling that before the pandemic, research is...

You do not currently have access to this content.